American Renal Associates (ARA) PT Lowered to $21 at BofA/Merrill Lynch Following UNH Agreement
Tweet Send to a Friend
BofA/Merrill Lynch lowered its price target on American Renal Associates (NYSE: ARA) to $21.00 (from $25.00) while maintaining a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
